NCT07515274Not yet recruiting
Evaluation of the Effects of Equicoaching on Social Reintegration Among Young Adults Who Have Been Treated for Cancer
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
This is a category 2 human research study (RIPH), interventional, single-center, prospective, open-label. The primary objective of this study is to qualitatively assess the effects of equicoaching on social reintegration in young adults who have been treated for cancer. The secondary objectives are to evaluate the contribution of equicoaching to: 1. Self-confidence; 2. Well-being 3. Quality of life Satisfaction with equicoaching will also be evaluated.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 2 Dec 2025
- Start date
- 5 Apr 2026
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- Centre Leon Berard
- Diseases
- Childhood cancers
- NCT number
- NCT07515274
What you commit to
- Study type: Interventional
- Planned participants: 10
- From 5 Apr 2026 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient deprived of liberty by judicial or administrative decision
- Pregnant or breastfeeding women
Who the study is looking for
- Have been treated for a malignant oncological or hematological condition.
- Be between 15 and 25 years of age at the time of cancer diagnosis. This age range corresponds to that chosen by the Leon Berard Cancer Center (CLB) and the Institute of Pediatric Hematology and Oncology (IHOPe) for the Adolescents and Young Adults with Cancer (DAJAC) program
- Have been treated at IHOPe/CLB as part of the DAJAC program
- Have completed intensive treatment within the last twelve months.
- Be able to understand, read, and write French
- Be affiliated with a health insurance plan
- Have been informed about the study and have given consent
- For minors:
- All of the above criteria
- Parent/legal guardian informed about the study and having given consent
Age in the registry: 15 years to 25 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CLB Coordinator of this site? Confirm its status | Lyon | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.